Ignite Creation Date:
2024-05-05 @ 11:43 PM
Last Modification Date:
2024-10-26 @ 10:39 AM
Study NCT ID:
NCT01407822
Status:
UNKNOWN
Last Update Posted:
2018-09-11
First Post:
2011-07-26
Brief Title:
Erlotinib Versus GemcitabineCisplatin as NeoAdjuvant Treatment in Non-small Cell Lung Cancer
Sponsor:
Guangdong Association of Clinical Trials
Organization:
Guangdong Association of Clinical Trials
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-12-05
Start Date Type:
ACTUAL
Primary Completion Date:
2018-04-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-12
Completion Date Type:
ESTIMATED
First Submit Date:
2011-07-26
First Submit QC Date:
August 1 2011
Study First Post Date:
2011-08-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-09-09
Last Update Post Date:
2018-09-11
Last Update Post Date Type:
ACTUAL